1. Alicea, C., Belkowski, S., Eisenstein, T.K., Adler, M.W., and Rogers, T.J., 1995, Inhibition of primary murine macrophage cytokine production in vitro following treatment with the κ-opiod agonist U50,488H, J. Neuroimmunol. 64: 83.
2. Chao, C.C., Gekker, G., Hu, S., Sheng, W.S., Bu, D.-F., Archer, S., Bidlack, J.M., and Peterson, P.K., 1996, Kappa opioid receptors in human microglia downregulate human immunodeficiency virus-1 expression, Proc. Natl. Acad. Sci. U.S.A., 93: 8051.
3. Ignatowski, T.A., and Bidlack, J.M., 1998, Detection of kappa opioid receptors on mouse thymocyte phenotypic subpopulations as assessed by flow cytometry, J. Pharmacol. Exp. Ther. 284:298.
4. Ignatowski, T.A., and Bidlack, J.M., 1999, Differential receptor expression on mouse lymphocytes at varying stages of maturation and on mouse macrophages after selective elicitation, J. Pharmacol. Exp. Ther., 290: 863.
5. Lawrence, D.M.P., El-Hamouly, W., Archer, S., Leary, J.F., and Bidlack, J.M., 1995, Identification of κ opioid receptors in the immune system an indirect immunofluorescence method, Proc. Natl. Acad. Sci. U.S.A. 92:1062.